The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HADV | -40% | -97.14% | -50.87% | -98% |
| S&P | +14.77% | +87.2% | +13.35% | +375% |
Health Advance, Inc. engages in the sale and supply of home medical products and services. It offers ambulatory products, bed accessories, catheters, diagnostic equipment, lift chairs, needles, syringes, medical gloves, specialty medical equipment and accessories, collection device, wheelchairs accessories and women-infant products. The company was founded by Jordan Starkman on April 14, 2010 and is headquartered in Colorado Springs, CO.
No news articles found for Health Advance.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | $0.00K | 0.0% |
| Market Cap | $64.40K | -88.2% |
| Market Cap / Employee | $21.47K | 0.0% |
| Employees | 3 | 0.0% |
| Net Income | -$10.92K | 5.9% |
| EBITDA | -$10.46K | 4.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | -$1.12K | -618.5% |
| Accounts Receivable | $36.23K | 0.0% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $254.07K | 0.0% |
| Short Term Debt | $47.88K | 91.9% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -10.27% | 1.4% |
| Return On Invested Capital | -41.91% | -11.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$5.21K | 30.0% |
| Operating Free Cash Flow | -$5.21K | 30.0% |
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -14.78 | -3.48 | -2.86 | -2.22 | -90.23% |
| Price to Tangible Book Value | -2.85 | -0.67 | -0.81 | -0.69 | -79.65% |
| Enterprise Value to EBITDA | -88.55 | -32.41 | -54.03 | -56.32 | -37.85% |
| Total Debt | $279.03K | $288.83K | $293.11K | $301.95K | 11.00% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
